Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Alfa Aesar Acquires Biomedical Technologies, Inc.

Published: Thursday, September 19, 2013
Last Updated: Thursday, September 19, 2013
Bookmark and Share
Alfa Aesar to leverage BTI’s manufacturing capabilities to enhance its product offering.

Alfa Aesar has announced that it has completed the purchase of Biomedical Technologies, Inc. (BTI) of Stoughton, Massachusetts.

BTI has been manufacturing life science research products for more than 30 years, with a commitment to its customers of technology, quality and value.

Its product line includes specialty proteins, cell culture additives and highly specific immunoassay tools, which Alfa Aesar will continue to build upon as it expands its portfolio of unique biochemical products for the researcher.

Commenting on the transaction, Julie Butterfield, General Manager of Alfa Aesar said: “Alfa Aesar is already known for providing researchers access to unparalleled expertise and supply of a wide variety of inorganic and organic chemicals used in both academia and industry. For our customers in the life sciences, we are committed to enhancing our offer in the biochemical arena through a selection of methodically chosen products that complement our current portfolio and build on our core competencies. The acquisition of BTI brings protein research and characterization, all types of profiling tools, and certain separation technologies and provides opportunities for Alfa Aesar to leverage BTI’s manufacturing capabilities to enhance its overall product offering.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,100+ scientific posters on ePosters
  • More Than 4,500+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

New Cambridge, Office for Alfa Aesar
New and exciting chapter in Alfa Aesar’s UK history.
Tuesday, June 02, 2015
Biomedical Technologies Enhances Lipoprotein Manufacturing Capabilities
Biomedical Technologies (BT) has doubled its ultracentrifuge capacity, enhancing manufacturing capabilities for custom products in response to market demand.
Monday, June 01, 2015
Alfa Aesar Introduces New “GET” Channel Partner Program
An excellent opportunity for new partners to emerge for Alfa Aesar.
Thursday, April 24, 2014
Scientific News
The Rise of 3D Cell Culture and in vitro Model Systems for Drug Discovery and Toxicology
An overview of the current technology and the challenges and benefits over 2D cell culture models plus some of the latest advances relating to human health research.
Injecting New Life into Old Antibiotics
A new fully synthetic way to make a class of antibiotics called macrolides from simple building blocks is set to open up a new front in the fight against antimicrobial drug resistance.
Insight into Bacterial Resilience and Antibiotic Targets
Variant of CRISPR technology paired with computerized imaging reveals essential gene networks in bacteria.
Advancing Protein Visualization
Cryo-EM methods can determine structures of small proteins bound to potential drug candidates.
Alzheimer’s Protein Serves as Natural Antibiotic
Alzheimer's-associated amyloid plaques may be part of natural process to trap microbes, findings suggest new therapeutic strategies.
Slime Mold Reveals Clues to Immune Cells’ Directional Abilities
Study from UC San Diego identifies a protein involved in the directional ability of a slime mold.
How Do You Kill A Malaria Parasite?
Drexel University scientists have discovered an unusual mechanism for how two new antimalarial drugs operate: They give the parasite’s skin a boost in cholesterol, making it unable to traverse the narrow labyrinths of the human bloodstream. The drugs also seem to trick the parasite into reproducing prematurely.
Illuminating Hidden Gene Regulators
New super-resolution technique visualizes important role of short-lived enzyme clusters.
Supressing Intenstinal Analphylaxis in Peanut Allergy
Study from National Jewish Health shows that blockade of histamine receptors suppresses intestinal anaphylaxis in peanut allergy.
Genes That Increase Children's Risk Of Blood Infection Identified
A team led by Oxford University has identified genes that make certain children more susceptible to invasive bacterial infections by performing a large genome-wide association study in African children.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,100+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!